Illumina, Inc.
$292.11
+3.32 · +1.15% today
Market open · updated 12:44:26 PM ET
- High
- $290.86 4:25 AM
- Low
- $288.32 4:10 AM
Against the S&P 500 Price change through Oct 28, 2026
ILMN+120.18%
S&P 500+13.26%
ILMN+195.29%
S&P 500+12.41%
ILMN+172.08%
S&P 500+88.06%
ILMN−28.14%
S&P 500+68.51%
Key numbers
- Previous close
- $288.79
- Open
- $286.05
- Day's range
- $283.00 – $292.85
- 52-week range
- $94.00 – $309.35
- Volume
- 655,374
- Average volume
- 2.5 million
- Market value
- $44.1 billion
- Price to earnings
- 53.4last 12 months
- Earnings per share
- $5.46last 12 months
- Beta
- 1.42moves about 1.4× as much as the market
- Dividend
- None
- 50-day average
- $247.14
- 200-day average
- $174.93
Thursday, Oct 29, 2026, after the close.
Analyst price targets and the full financials are in the terminal.
Who Illumina competes with From our value chain
Illumina in the news
No desk stories on ILMN yet. When we write about it, the story leads this list.
- HeadlineIllumina (ILMN) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research · October 28, 2026 at 10:16 AM ET
- HeadlineIllumina To Webcast Upcoming Investor ConferencePRNewsWire · October 27, 2026 at 4:15 PM ET
- HeadlineIllumina (ILMN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research · October 22, 2026 at 11:02 AM ET
- HeadlineIllumina: NovaSeq X And Consumables Sustain MomentumSeeking Alpha · October 22, 2026 at 10:16 AM ET
- HeadlineILMN Q3 Earnings Preview: Strong Clinical Demand May Lift PerformanceZacks Investment Research · October 22, 2026 at 9:45 AM ET
- HeadlineIllumina BioInsight Platform expands with new software to accelerate the path from sequencing to discoveryPRNewsWire · October 21, 2026 at 9:15 AM ET
- HeadlineWill Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · October 16, 2026 at 1:10 PM ET
- CongressGilbert Cisneros bought $1,001 - $15,000 of ILMNHouse filing · disclosed Mar 10, 2026
Earnings
Next report: Thursday, Oct 29, 2026, after the close.
Congress trades in ILMN
The latest 3 filings are all purchases.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Feb 10, 2026 | Mar 10, 2026 |
| Lisa McClainHouse · R-Michigan | Purchase | $1,001 - $15,000 | Jun 9, 2025 | Aug 13, 2025 |
| Thomas H. KeanHouse | Purchase | $1,001 - $15,000 | Apr 1, 2025 | Apr 21, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Illumina
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 8,600
- Headquarters
- San Diego, California
- Website
- illumina.com
- Listed
- Jul 28, 2000
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.